I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Abuasab, Tareq
13
results:
Articles (Online) X
Search for persons
X
Sorted by: Relevance
Sorted by: Year
?
1
Exploring the landscape of somatic ASXL2 mutations in myelo..:
Abuasab, Tareq
;
Borthakur, Gautam
;
Kanagal‐Shamanna, Rashmi
...
American Journal of Hematology. 99 (2024) 7 - p. 1434-1436 , 2024
Link:
https://doi.org/10.1002/..
?
2
Oral decitabine and cedazuridine plus venetoclax for older ..:
Bazinet, Alexandre
;
Garcia-Manero, Guillermo
;
Short, Nicholas
...
The Lancet Haematology. 11 (2024) 4 - p. e276-e286 , 2024
Link:
https://doi.org/10.1016/..
?
3
Myeloid lineage switch in KMT2A-rearranged acute lymphoblas..:
Bataller, Alex
;
Abuasab, Tareq
;
McCall, David
...
Haematologica. , 2023
Link:
https://doi.org/10.3324/..
?
4
Outcomes of adult patients with relapsed/refractory CRLF2 r..:
Desikan, Sai Prasad
;
Senapati, Jayastu
;
Jabbour, Elias
...
American Journal of Hematology. 98 (2023) 6 - p. , 2023
Link:
https://doi.org/10.1002/..
?
5
P730: EVOLUTION OF IPSS-M RISK CATEGORIES IN PATIENTS WITH ..:
Chien, Kelly
;
Urrutia, Samuel
;
LI, Ziyi
...
HemaSphere. 7 (2023) S3 - p. e08202e6 , 2023
Link:
https://doi.org/10.1097/..
?
6
AML-328 Phase 2 Study of ASTX727 (Decitabine/Cedazuridine) ..:
Abuasab, Tareq
;
Alvarado, Yesid
;
Issa, Ghayas
...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S237 , 2022
Link:
https://doi.org/10.1016/..
?
7
AML-387 Clinical Characteristics of Secondary Myeloid Neopl..:
Abuasab, Tareq
;
Mohamed, Shehab F.
;
Biostatistics, Hyunsoo Hwang
...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S243 , 2022
Link:
https://doi.org/10.1016/..
?
8
Poster: AML-325 Prognostic Impact of RAS and C-KIT Mutation..:
Abuasab, Tareq
;
Senapati, Jatastu
;
Kadia, Tapan
...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S133 , 2022
Link:
https://doi.org/10.1016/..
?
9
Poster: AML-328 Phase 2 Study of ASTX727 (Decitabine/Cedazu..:
Abuasab, Tareq
;
Alvarado, Yesid
;
Issa, Ghayas
...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S125 , 2022
Link:
https://doi.org/10.1016/..
?
10
AML-325 Prognostic Impact of and Mutations (Single vs. Mult..:
Abuasab, Tareq
;
Senapati, Jatastu
;
Kadia, Tapan
...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S235-S236 , 2022
Link:
https://doi.org/10.1016/..
?
11
Poster: AML-387 Clinical Characteristics of Secondary Myelo..:
Abuasab, Tareq
;
Mohamed, Shehab F.
;
Biostatistics, Hyunsoo Hwang
...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S134 , 2022
Link:
https://doi.org/10.1016/..
?
12
Common kinase mutations do not impact optimal molecular res..:
Senapati, Jayastu
;
Abuasab, Tareq
;
Haddad, Fadi G.
...
American Journal of Hematology. 98 (2022) 3 - p. , 2022
Link:
https://doi.org/10.1002/..
?
13
Emerging Monoclonal Antibody Therapy for the Treatment of A..:
Abuasab, Tareq
;
Rowe, Jacob
;
Tvito, Ariella
Biologics: Targets and Therapy. 15 (2021) - p. 419-431 , 2021
Link:
https://doi.org/10.2147/..
1-13
